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There is substantial lack in the understanding of the role of host lipids in virus 
infections, and this project aimed to identify possible lipid candidates that could be 
crucial during influenza virus replication. Based on our previous experiments 
identifying an enrichment of ether lipids in influenza virus particles and influenza 
virus-infected human alveolar adenocarcinoma cells (A549) (our lab’s unpublished 
data), I established the lipid profiles of influenza virus-infected Chinese hamster 
ovary (CHO-K1) wild-type (WT) cells and its ether lipid-deficient derivatives, NRel-
4, using high performance liquid chromatography (HPLC) mass spectrometry. Similar 
to the observations in influenza virus-infected A549 cells, many choline containing 
lipids such as phosphatidylcholine (PC) and sphingomyelin (SM) lipid species were 
significantly different in infected cells, compared to mock-infected cells. There was a 
specific increase in ether phosphatidylcholine (ePC) species in influenza virus-
infected CHO-K1 cells, but a decrease in ester phosphatidylcholine (aPC) species. 
This trend in PC lipid species however, was not distinct in NRel-4, indicating the 
misregulation of ether lipids in these NRel-4 cells. Based on this observation, I 
postulated that ePCs might play important roles in influenza virus infection and 
hence, designed functional assays to further elucidate their roles. For this purpose, 
NRel-4 cells were infected with influenza virus and a decrease in influenza virus titers 
were observed, as compared to the CHO-K1 wild-type cells. To further confirm the 
importance of ether lipids during influenza virus infection, I harnessed a siRNA 
knockdown approach targeting alkylglycerone phosphate synthase (AGPS), the 
enzyme catalyzing the second step of ether lipid biosynthesis, in A549 cells. 
Intriguingly, a 60 to 70% reduction in virus titer was also observed in AGPS 
 viii 
knockdown cells. Based on these data and other published literature, it was 
hypothesized that ePCs could play important roles in the completion of influenza 
virus life cycle stages, especially at later stages of infection, including trafficking, 
assembly and budding. This hypothesis is mainly attributed to the observation that 1) 
trafficking vesicles like synaptic vesicles are enriched in ether lipids, 2) ether lipids 
are involved in cholesterol homeostasis and protein trafficking, and 3) M2-mediated 
membrane scission of influenza virus, is regulated by cholesterol levels at the budding 
site. It was further postulated that ether lipid biosynthesis could be regulated by the 
glycolytic flux in host cells, since the ether lipid biosynthetic pathway branches from 
dihydroxyacetone phosphate (DHAP) in the glycolytic pathway, and glycolytic flux 
has been implicated in many virus infections, including influenza virus.  
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1.1 Influenza virus 
1.1.1 Epidemiology of influenza 
Influenza virus is a common human pathogen that causes the febrile respiratory 
disease, influenza, which is more commonly known as “flu”. Influenza virus infection 
can lead to serious respiratory illnesses and worsen other chronic conditions such as 
cardiopulmonary diseases, hence accounting for high mortality and morbidity rates 
(Cox and Subbarao, 2000). A sudden surge in influenza virus infections among the 
human population can result in epidemic seasons and pandemic reoccurrences. The 
figure below provides an illustration by the World Health Organisation (WHO) of the 
transmission patterns of different influenza virus strains in a stated week 
(http://www.who.int/influenza/surveillance_monitoring/updates/2012_03_02_influenz
a_update_154_week_07_main.jpg, assessed 13 March 2012) (Figure 1.1). The most 
recent case of an influenza pandemic occurred in 2009, with the emergence of H1N1 
swine flu virus that saw a worldwide spread to more than 214 countries and 
communities, following an approximation of 18 000 deaths, as of 1
st
 August 2010, 
when the WHO announced the end of the pandemic 
(http://www.who.int/csr/don/2010_08_06/en/index.html, accessed 13 March 2012). 
The 2009 H1N1 pandemic, second of two H1N1 pandemics, was found to have 
conceived due to the reassortment of gene segments between two swine viruses 
(Zimmer and Burke, 2009). The first H1N1 pandemic, the 1918 Spanish flu 
pandemic, is reportedly the most catastrophic pandemic in human history that have 
simultaneously infected both humans and pigs, and killed 40 to 50 million people, 
mainly healthy young adults (Khanna et al., 2009; Ma et al., 2011; Zimmer and 
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Burke, 2009). The hemagglutinin (HA) gene of the 2009 H1N1 pandemic was found 
to have derived from the 1918 Spanish pandemic (Ma et al., 2011). In recent years, 
efforts have been made to reconstruct the 1918 influenza virus using reverse genetics, 
to better understand the virulence and lethality of this strain of virus, and ideally to 
provide insights into the ability to cause future pandemics (Tumpey et al., 2005).  
 
Figure 1.1 Estimates of the transmission of influenza virus strains in a given week in 2012.  
The coloured regions represent the percentage of respiratory specimens tested positive for influenza, 
and the pie charts represent the distribution of virus subtypes (WHO, 2012). 
 
Influenza viruses are enveloped viruses belonging to the Orthomyxoviridae family 
(Nayak et al., 2004), and are categorized into three subtypes, influenza A, B and C 
(Lamb and Choppin, 1983). Influenza A viruses are distinguished by the antigenic and 
genetic properties of their surface glycoproteins, HA and neuraminidase (NA) (Lamb 
and Choppin, 1983). Individuals are incessantly susceptible to newer and more 
virulent strains of influenza virus, due to the antigenic variations of influenza virus 
that can occur through antigenic drift and antigenic shift (Cox and Subbarao, 2000). 
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Antigenic drifts are caused by mutations in the genes encoding the virus surface 
proteins HA and NA, while antigenic shifts, which are specific only to influenza A 
viruses, are brought about by the introduction of a HA either from an animal or avian 
species, to the human population, or when reassortment of the gene segments occur 
between animal and human influenza viruses (Cox and Subbarao, 2000). With 
antigenic variations, vaccinations against previous strains may no longer be effective 
against new strains (Cox and Subbarao, 2000). Epidemiology studies have also 
revealed that the increase in influenza virus vaccination rate does not translate to a 
reduction in influenza virus mortality and hospitalization rates (Rizzo et al., 2006; 
Thompson et al., 2004; Thompson et al., 2003). Besides, outbreaks of influenza virus 
strains can potentially cause epidemic and pandemic seasons, which can pose a major 
burden on global health. These evidences indicate the need for further breakthroughs 
in the study of effective vaccines and drugs against influenza virus.  
 
1.1.2 Structure and function of influenza virus 
Influenza viruses are negative stranded ribonucleic acid (RNA) viruses (Nayak et al., 
2004), mainly spherical in shape and about 80 to 120nm in diameter (Lamb and 
Choppin, 1983). Influenza virions are surrounded by a lipid envelope derived entirely 
from the host cell plasma membrane during the process of budding (Nayak et al., 
2004). Transmembrane proteins like matrix protein 2 (M2) (Nayak et al., 2004), HA 
and NA are distributed across the envelope, producing spike-like formations on the 
virus periphery (Lamb and Choppin, 1983). Matrix protein 1 (M1) proteins are found 
beneath the lipid envelope, followed by a viral core that packages the eight segments 
of viral RNA (vRNA), together with nucleoprotein (NP), into viral nucleoprotein 
1. Introduction  
 
5 
complexes (vRNP) (Wu et al., 2007). The viral genome also consists of RNA 
polymerase complex proteins such as basic polymerase 1 (PB1), basic polymerase 2 
(PB2), acidic protein and the non-structural proteins (NS) which are solely expressed 
in infected cells (Rossman and Lamb, 2011).  
 
 
Figure 1.2 Structure of an influenza virion.  
NA, HA and M2 proteins are distributed across the virus envelope, M1 proteins are found beneath the 
envelope, and the NP proteins together with the segmented vRNA, form viral nucleoprotein complexes 
in the viral core (Nelson and Holmes, 2007). 
 
Influenza viruses hijack the host cell machinery and enter by receptor-mediated 
endocytosis (Lakadamyali et al., 2004). HA is important in influenza virus life cycle, 
providing binding sites for receptors during entry of influenza virus particles (Nayak 
et al., 2004). Cleavage and a low pH-triggered conformational change of HA allows 
for efficient fusion of the virus particle with late endosomal membranes (Skehel and 
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Wiley, 2000), producing the formation of a membrane pore wide enough for the  
release of vRNA into the host cytoplasm (Biswas et al., 2008). vRNA is subsequently 
imported into the nucleus for replication and transcription, and this process is 
mediated by the nuclear localization sequence (NLS) found on NP proteins (Wu et al., 
2007). The NS1 protein has also been attributed to the efficient replication of 
influenza virus by regulating vRNA synthesis, controlling the viral messenger RNA 
(mRNA) splicing and also by suppressing the host immune response (Hale et al., 
2008). Subsequently, NS2 (NEP) protein is involved in the export of vRNP out of the 
nucleus (Rossman and Lamb, 2011). Influenza M2 proteins are multifunctional 
proteins, mediating entry, assembly and budding stages of the influenza virus life 
cycle (Rossman and Lamb, 2011). M2 protein is important for uncoating vRNP from 
M1 proteins, releasing vRNP for replication (Nayak et al., 2004). It was also recently 
reported that the cytoplasmic tail of M2 protein has a crucial role in assembly (Chen 
et al., 2008) and budding (Rossman et al., 2010a) of influenza virus. NA plays a final 
role in releasing virus progeny from the cell surface, by cleaving off the binding 
between the virus and sialic acid modified glycoproteins and lipids. This step of the 
virus life cycle represents an attractive target for antiviral therapy and for example, 
the popular antiviral drug Oseltamivir (Tamiflu), inhibits NA activity of influenza 
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1.2 Involvement of host factors in influenza virus infection 
Influenza virus requires the use of host cell machinery for replication and for 
completion of its life cycle stages (Konig et al., 2010). Evolution has allowed viruses 
to develop diverse strategies to evade the host immune system, extending the window 
of time for replication (Vossen et al., 2002). It has been recently reported that 
influenza virus (Uetani et al., 2008), like sendai virus (Garcin et al., 2000) and human 
parainfluenza virus (Gao et al., 2001), subverts host immune response by interfering 
with the interferon signalling pathway in host cells. Therefore, it is evident that 
viruses, including influenza virus, hijack host cell mechanisms to evade host defence 
mechanisms and to allow efficient progression of their life cycle stages. 
 
1.2.1 Genome studies identifying host factors involved in influenza virus 
infection  
The first genome-wide short-interfering RNA (siRNA) screen identifying host factors 
involved in influenza virus infection was completed in Drosophila, where 30,071 
genes (90% of Drosophila genome) were screened, of which 110 genes were found to 
affect reporter gene expression of the influenza virus-like RNA, when depleted (Hao 
et al., 2008). Subsequently, three Drosophila genes with their human homologues 
were validated on mammalian cells and found to be important for H5N1 and H1N1  
influenza virus replication (Hao et al., 2008). These three genes, ATP6V0D1, 
COX6A1 and NFX1 are involved in endocytosis, mitochondrial function and in the 
nuclear export of mRNA respectively (Hao et al., 2008). Recently, with the 
advancement in establishing mammalian genome-wide siRNA screens, several 
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additional studies have made significant contributions to the comprehensive analysis 
of the involvement of mammalian host cell factors in influenza virus infection (Brass 
et al., 2009; Hao et al., 2008; Karlas et al., 2010; Konig et al., 2010; Shapira et al., 
2009; Sui et al., 2009). Watanabe et al. (2010) reviewed six recent genome-wide 
screens and identified approximately 1400 human genes to be potentially involved in 
influenza virus replication (Watanabe et al., 2010). A more stringent pair-wise 
comparison between the six independent screens was implemented and 128 human 
genes were observed to be associated with influenza virus infection in at least two of 
the six screens (Watanabe et al., 2010). The 128 genes comprise genes with a diverse 
range of functions, including genes involved in transcription, translation, and 
endocytosis (Watanabe et al., 2010), and these are cellular processes notably essential 
for influenza virus replication. These screens highlight the importance of host cell 
factors for influenza virus replication, and host proteins, host lipids and host cell 
metabolism possibly play crucial roles in influenza virus life cycle progression. 
 
1.2.2 Host proteins and their involvement in influenza virus infection 
Several papers have reported the crucial role of host proteins in influenza virus 
infection. Coombs et al. (2010) reported the regulation of many host proteins after 
A549 cells were infected with human influenza virus A/PR/8/34 (H1N1) virus 
(Coombs et al., 2010). In this study, the stable isotope labelling by amino acids in cell 
culture (SILAC) approach was adopted, coupled to a quantitative mass spectrometry 
(MS)-based technique, hence providing wider protein coverage and allowing the 
analysis of 4700 cytosolic protein pairs. Of these, 127 proteins were significantly up-
regulated and 153 proteins were significantly down-regulated in influenza virus-
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infected cells (Coombs et al., 2010). The up-regulated proteins are those involved in 
transcription pathways, immune response, and cell structure, while those down-
regulated have main roles in nucleic acid metabolism, cytoskeletal regulation and 
transport pathways (Coombs et al., 2010). Several other proteomic studies 
incorporated two-dimensional gel separation methods and identified much lesser 
number of host proteins that were regulated during an influenza virus infection. 
Similarly, proteins involved in cytoskeletal regulation, protein synthesis, cell 
signalling and apoptosis were among those altered during an influenza virus infection 
(Liu et al., 2008; Vester et al., 2009). 
 
Besides changes in protein expressions, alterations in subcellular localization of 
proteins were also observed in influenza virus-infected cells (Lietzen et al., 2011). 
Striking changes were observed in the mitochondrial and nuclear proteome. The 
subcellular localization of Ras-related small GTPases and vacuolar ATPases, which 
are regulators of the endosomal recycling pathway, changed dramatically (Lietzen et 
al., 2011). Secretome data suggested that several Ras-related proteins such as Rab10, 
Rab11A and Rab1A, and components of vacuolar ATPases were rapidly secreted 
during the onset of influenza virus infection, and hence these proteins might be 
implicated in protein secretion during an infection (Lietzen et al., 2011). This study 
emphasizes the ability for subcellular proteomic analysis to provide insights in host 
cellular response during an infection, that otherwise may not be observed at a whole 
cell proteome level (Lietzen et al., 2011). 
 
Enveloped viruses like influenza virus enter the host cells by membrane fusion and 
bud off either at the plasma membrane or from cellular membranes. This process 
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might lead to the association of host proteins into the virus particles, indicating either 
the requirement of these host proteins for various stages of virus life cycle, or 
suggesting the non-specific incorporation of proteins that are rich in the virus budding 
sites (Shaw et al., 2008). In addition to the nine viral proteins derived from the 
influenza virus genome, 36 host proteins have also been found to be present in 
influenza virions (Shaw et al., 2008). These host proteins consist of cytoskeletal 
proteins and glycolytic enzymes (Shaw et al., 2008). The finding that influenza virus, 
like human immunodeficiency virus (HIV), buds from specific lipid microdomains 
known as “lipid rafts”, makes it unsurprising to find lipid raft-resident proteins 
incorporated into the virions. These proteins include glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), annexins, tubulin, actin, enolase and 
glycophosphatidylinositol (GPI)-anchored protein, CD59 (Shaw et al., 2008). 
Annexins are calcium-dependent phospholipid-binding proteins and are also identified 
to behave as scaffolding proteins at membrane domains (Shaw et al., 2008). Studies in 
other RNA viruses like human immunodeficiency virus type 1 (HIV-1) (Chertova et 
al., 2006; Saphire et al., 2006) and Moloney murine leukaemia virus (MoMLV) 
(Segura et al., 2008), have also identified host proteins in virions. Evidences of host 
proteins integrated into virus particles could imply the functional importance of these 
host proteins for virus infections. 
 
In summary, comprehensive proteomic studies have contributed to the understanding 
of host protein-virus interactions, and have broadened our knowledge of cellular 
requirements needed for efficient viral propagation, providing also functional 
relevance of some of these proteins for specific virus life cycle stages (Shugar, 1999). 
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1.2.3 Involvement of host metabolism in influenza virus infection 
During an infection, many processes such as biosynthesis of macromolecules required 
for virus replication, antiviral defence mechanism and apoptosis can cause changes in 
metabolism of host cells (Ritter et al., 2010). Because viruses depend on host 
metabolism for basic energy and building blocks for replication, studying of systems 
level metabolite profile can identify potential targets for antiviral strategies. As 
described in Munger et al. (2008), an increase in the efflux of fatty acid biosynthesis 
and nucleotide synthesis have been identified during human cytomegalovirus 
(HCMV) infection (Munger et al., 2008), and the inhibition of nucleotide synthesis 
has been clinically known as an anti-metabolite treatment approach for HCMV 
(Andrei et al., 2008). This highlights the potential of metabolite profiling in 
establishing new treatment approaches for diseases and infections.  
 
1.2.3.1 Glycolytic flux in influenza virus infection 
Many viruses like HCMV (Munger et al., 2006; Munger et al., 2008), have been 
observed to increase the rate of glycolysis, and elevate the flux of fatty acid 
biosynthesis and pyrimidine nucleotide biosynthesis in infected host cells. Similarly, 
metabolomic studies have observed an escalation of metabolite levels mainly at the 
upper part of the glycolytic pathway, at 12 hours (hrs) after influenza virus infection 
and onwards (Ritter et al., 2010). This observation was coupled with the increase in 
uptake of extracellular glucose and an increase in lactate accumulation in cell culture 
supernatant (Ritter et al., 2010). Initiation of apoptosis during late stage of influenza 
virus infection is hypothesized to be the reason for an increase in glycolytic flux only 
after 12 hours post infection (hpi)  (Ritter et al., 2010).  In an earlier study conducted 
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by Klemperer (1961), uptake and breakdown of glucose was found to be elevated 
during the early stages of influenza virus infection, and this was postulated to arise 
due to the need for energy during virus synthesis (Klemperer, 1961). Though differing 
observations were reported in these two influenza virus metabolomic studies, we can 
still be certain that an infection does cause a change in the metabolism of host cells, 
but the metabolic response could differ between cell lines, virus strains and culture 
conditions. 
 
1.2.3.2 Lipid metabolism in influenza virus infection 
Lipids play a role in a diverse range of functions and biological processes in a cell. 
Briefly, their functions include maintaining the structure of cell membranes, serving 
as an energy storage, and being involved in membrane trafficking and cellular 
signalling processes (van der Meer-Janssen et al., 2010). Such heterogeneity in 
function makes lipids a good target for pathogens, and hence, there have been 
increasing evidences of lipid involvement in host-pathogen interactions (van der 
Meer-Janssen et al., 2010; Wenk, 2006). Enveloped viruses for example, derive their 
lipid envelope from host cell membranes during budding (Nayak et al., 2004). This 
lipid composition could possibly have important roles in immunogenicity of the virus, 
based on the finding that delipidated simian immunodeficiency virus was able to 
enhance host cell immune response (Kitabwalla et al., 2005). Recently, Wolf et al. 
(2010) also identified a small antiviral molecule that inhibits all enveloped viruses, 
targeting the viral lipid membrane and disrupting virus-cell fusion, by exploiting the 
non-reparative property of virus particles (Wolf et al., 2010). This molecule 
specifically affect virus-cell fusion and not cell-cell fusion (Wolf et al., 2010). Also, 
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in a number of virus studies done on hepatitis C virus (HCV) (Ikeda and Kato, 2007; 
Kapadia and Chisari, 2005), HIV (Amet et al., 2008)  and respiratory synctial virus 
(Gower and Graham, 2001), disrupting lipid metabolism with the use of statins have 
been found to inhibit virus replication, accentuating the importance of lipid 
metabolism in virus infections. Besides, many viral fusion glycoproteins (HA of 
influenza viruses and Env of retroviruses) require specific interactions with lipid 
microenvironment for efficient virus fusion (Bhattacharya et al., 2004; Takeda et al., 
2003). 
 
Lipids are hard to define, chemically distinct molecules. Though most definitions 
state that lipids are highly soluble in organic solvents, there are still a number of lipids 
that will escape the organic extraction (Wenk, 2005). Dr Christie (The Lipid Library) 
has broadly defined lipids as fatty acids and their naturally-occurring derivatives, or 
their biosynthetically or functionally related compounds (Wenk, 2005). There has 
been growing emphasis on the importance of lipidomics, which involves the analysis 
of lipids and their interacting partners at systems level (Wenk, 2005). The emergence 
of more advanced analytical methods such as mass spectrometry and chromatography 
provide an exciting platform for lipidomics research, and this advancement can 
potentially be applied to biomedical research in drug and biomarker development 
(Wenk, 2005). With the increasing data generated by the lipid community, a detailed 
classification scheme of lipids would facilitate communication (Fahy et al., 2005). An 
attempt to build a comprehensive classification system have led to a categorization of 
lipids into eight main classes, namely fatty acyls, glycerolipids, glycerophospholipids, 
sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides (Fahy et al., 
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Figure 1.3 Structures of main lipid classes. 
Structures of the five prominent lipid classes are indicated above. Figure was taken from (Wenk, 2005). 
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Fatty acyls are the major building block of complex lipids, contributing to 
hydrophobicity of lipids and glycerolipids. They are mainly glycerol-containing lipids 
with mono-, di- or tri- substituted glycerols (Fahy et al., 2005). Glycerophospholipids 
are an abundant class of glycerolipids and can be divided into subclasses based on the 
polar head groups attached at the glycerol backbone (Fahy et al., 2005), giving rise to 
phosphatidylcholines, phosphatidylserines, phosphatidylethanolamines, etc. 
Glycerophospholipids can also exist as ether-bonded glycerophospholipids (Figure 
1.4), where the alkyl chain at the sn-1 position is linked to the glycerol backbone via 
an ether bond (Gorgas et al., 2006). Among these ether glycerophospholipids are lipid 
species with a vinyl ether linkage (plasmalogens), and these are most abundant in 
mammalian tissues (Gorgas et al., 2006). However, for simplicity, this project does 
not differentiate between the two different subclasses of ether lipids, and ether linkage 
in the PC and PE classes will be denoted by ePC and ePE respectively, while the 
usual esterified lipids will be denoted by aPC and aPE. Sphingolipids have a 
sphingoid base backbone that is generated from serine and a long-chain fatty acyl-
Coenzyme A (CoA) (Fahy et al., 2005). Other sphingolipid species such as ceramides 
(Cer), phosphosphingolipids (eg, sphingomyelins (SM)) and glycosphingolipids 
(GSLs) are then derived from this common structure (Fahy et al., 2005). Sterol lipids 
will constitute cholesterol and its derivatives, and together with glycerophospholipids 
and SMs, are important membrane lipids (Fahy et al., 2005). The main organelle for 
lipid biosynthesis is the endoplasmic reticulum (ER), and some lipid biosynthesis, 
largely sphingolipid biosynthesis occurs in the Golgi (van Meer et al., 2008). 




Figure 1.4 Structures of ester-linked and ether-linked PC (18:0/20:4) lipid species. 
Glycerophospholipids, in this case, 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
phosphocholine (PC (18:0/20:4)) are esterified with long chain fatty acids at the glycerol backbone.  
An ether linkage at the sn-1 position produces a plasmanyl lipid species, 1-octadecyl-2-
(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine (PC(O-18:0/20:4)), and a vinyl ether 
linkage produces a plasmenyl lipid species, 1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-
sn-glycero-3-phosphocholine (PC(P-18:0/20:4)).  
 
The interest of this project pivots around the involvement of lipids during an influenza 
virus infection. There is still a substantial lack in the understanding of the role of 
lipids during virus infections, especially influenza virus. However, new findings are 
surfacing with the advances in analytical methods (Wenk, 2006), and a brief overview 








Enveloped viruses like influenza virus enter host cells by interacting with specific 
receptors on the cell surface. This interaction leads to a conformational change of the 
virus surface glycoprotein HA, allowing lipid mixing between viral and host cell 
membranes, resulting in the formation of a membrane pore that releases viral 
components into host cells (Chan et al., 2010). Lipids such as GSLs have also been 
observed to be involved in the entry process of influenza virus. Sialic-acid containing 
GSLs, such as gangliosides, can act as receptors and bind to influenza virus HA, the 
viral protein essential for viral attachment, resulting in infection of host cells (Hidari 
et al., 2007). However, there have been contradicting findings indicating that 
gangliosides are not essential for influenza virus infection (Matrosovich et al., 2006b), 
and that N-linked glycoproteins rather than O-linked glycoproteins are the main 
receptors for influenza virus entry (Chu and Whittaker, 2004). Hence, the O-linked 
GSLs might possibly be playing a supportive role in influenza virus entry, since 
studies have indicated that an enrichment of the ganglioside GM3, which consist of a 
GSL linked with one sialic acid on the sugar chain, increases the binding rate of 
influenza viruses (Sato et al., 1996). Other cellular functions of sphingolipids have 
also been associated with the late stage of influenza virus infection, where the 
inhibition of sphingolipids, including GSLs show alteration to the distribution of HA 
and hence affecting the maturation of virus particles (Hidari et al., 2006). It is 
postulated that GSLs may therefore contribute not just in the viral attachment process, 
but are also crucial for later stages of trafficking and assembly of viral components 
(Hidari et al., 2006).  
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1.2.3.2.2 Neutral lipids 
Sterol lipids are important components of membrane lipids (Simons and Ikonen, 
2000), and it has been proposed that the membrane bilayer is not passively structured 
but rather, involves enrichment of sphingolipids and cholesterol into specific lipid 
microdomains for organized functions (Lingwood and Simons, 2010). Such lipid 
microdomains known as lipid rafts, were first suggested by Brown and Rose (1992) 
when they identified that sphingolipids and GPI-anchored proteins in cell membranes 
were detergent resistant, with a characteristic density following density centrifugation 
(Brown and Rose, 1992). Cholesterol tightly packs the sphingolipids in these ordered 
domains by sitting between spaces in the hydrocarbon chains of sphingolipids 
(Simons and Ikonen, 2000), and these assemblies of microdomains have been 
associated with functions in trafficking, signal transduction and cell polarization 
(Lingwood et al., 2009). Proteins destined for apical delivery to the apical side of the 
plasma membrane, such as GPI-anchored proteins (Brown and Rose, 1992) and 
glycoprotein gp-80 (Keller and Simons, 1998) were postulated to rely on these 
microdomains for apical sorting signals. Protein transport via endocytic pathways also 
involve lipid rafts, and clustering of GPI-anchored proteins can activate many 
signalling pathways (Simons and Ikonen, 1997). Lipid rafts may also be important for 
influenza virus infection, since the apical transmembrane influenza virus HA protein 
was found to be associated with lipid rafts (Simons and Ikonen, 1997; Skibbens et al., 
1989). Moreover, the depletion of cholesterol and therefore the reduction of lipid raft 
formation resulted in a slower transport of the HA to the apical plasma membrane 
(Keller and Simons, 1998). 
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Besides the importance of cholesterol in raft formation, cholesterol also has a 
diversity of roles to play in an influenza virus infection. Notably, cholesterol has been 
implicated in un-coating and entry of the virus, transport of viral proteins, and 
assembly and budding of the virus particle (Nayak et al., 2004; Takeda et al., 2003). 
More recently, it was also suggested that cholesterol plays a role in many stages of 
membrane fusion, including membrane mixing, an essential process prior to formation 
of a fusion pore, and also the later stage of membrane fusion, which involves fusion 
pore expansion (Biswas et al., 2008). A collective activity of HA trimer is associated 
with efficient fusion in influenza virus particles (Danieli et al., 1996; Takeda et al., 
2003), and it is postulated that viral envelope cholesterol is needed for the formation 
of HA trimer (Sun and Whittaker, 2003). Depleting cholesterol results in an increase 
in gel-phase lipids that could cripple the mobility and aggregation of HA trimers, 
accounting for the inhibition of virus fusion (Polozov et al., 2008). Sun and Whittaker 
(2003) also reported that depleting the influenza virus lipid envelope of cholesterol, 
by treatment of methyl-ß-cyclodextrin (MßCD), impairs the infectivity of the virus 
particle. This could be due to the impairment of fusion between virus particles and 
host cell membranes, or possibly due to the production of more “leaky” virus particles 
as a result of a depletion of cholesterol in the virus envelope  (Sun and Whittaker, 
2003). It was further reported that although depleting host cell cholesterol similarly by 
MßCD treatment increases the number of influenza virus particles produced, the 
infectivity of these virus particles are greatly reduced (Barman and Nayak, 2007). 
These two studies could suggest a need for a tight regulation of cholesterol levels in 
cells for efficient budding and infectivity of influenza virus particles. Cholesterol 
levels at the budding site are found to be important for M2-mediated budding, where 
the binding of influenza virus M2 protein to cholesterol is associated with membrane 
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bending and membrane scission (Chen et al., 2008; Rossman and Lamb, 2011). The 
enrichment of cholesterol and other saturated lipids at the budding site was also 
proposed to ensure the stability of influenza virus particles during airborne 
transmission (Polozov et al., 2008), preventing the leakage of viral components that 
will compromise the infectivity of virus particles (Barman and Nayak, 2007). 
However, addition of exogenous cholesterol could also increase rigidity of cell 
membranes and could inhibit membrane fission and bud release (Barman and Nayak, 
2007), further supporting the importance of tightly regulated cholesterol levels at the 
budding site. It seems likely that cholesterol enrichment in raft microdomains may be 
required only to initiate a bud formation and facilitate membrane curvature, but bud 




Glycerophospholipids are the main structures in eukaryotic membranes, consisting of 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI) and phosphatidic acid (PA) (van Meer et al., 2008). PCs 
account for more than 50% of the phospholipids in the membrane bilayer (van Meer 
et al., 2008), and enveloped viruses like influenza virus, that bud from the host plasma 
membrane will derive their lipid envelope entirely from the host plasma membrane, 
reflecting the lipid composition of the budding site (Nayak et al., 2004; van Meer and 
Simons, 1982). A study conducted on enveloped viruses, HIV-1 and murine leukemia 
virus (MLV) have also identified lipid compositions similar to their budding site, the 
plasma membrane, which is unique from the total cell lipid (Chan et al., 2008). 
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Influenza virus and vesicular stomatitis virus (VSV) buds from the apical and 
basolateral plasma membrane respectively, and early studies have identified 
differences in their phospholipid compositions (van Meer and Simons, 1982). 
Influenza virus buds from sphingolipid-cholesterol enriched microdomains (Gerl et 
al., 2012; Scheiffele et al., 1999), while VSV buds from raft-depleted microdomains 
(Keller and Simons, 1998), and it has been found that poly-unsaturated phospholipids 
are increased in the presence of cholesterol accumulation, in the case of influenza 
virus, where the budding site is cholesterol rich (Blom et al., 2001). The poly-
unsaturated phospholipids are proposed to serve to enhance membrane fluidity in the 
presence of an otherwise rigid structure (Blom et al., 2001). Phospholipids therefore, 
could play important functions in virus infections, including influenza virus 
infections. 
 
Another subclass of glycerophospholipids include the ether-linked phospholipids, 
consisting mainly of ether phosphatidylcholine (ePC) and ether 
phosphatidylethanolamine (ePE) species (Wallner and Schmitz, 2011). The first two 
enzymatic reactions for ether lipid biosynthesis take place in the peroxisomes, 
catalyzed by dihydroxyacetonephosphate acyltransferase (DHAPAT) and alkyl-
dihydroxyacetonephosphate synthase (AGPS) (Honsho et al., 2008). DHAPAT 
esterifies the hydroxyl group of the dihydroxyacetone phosphate (DHAP), and AGPS 
forms the ether bond by attaching a long chain fatty alcohol at the sn-1 position 
(Nagan and Zoeller, 2001). Fatty acyl-CoA reductase (FAR) is an enzyme that 
reduces fatty acyl-CoA to a fatty alcohol and CoA-SH, providing fatty alcohol needed 
for ether lipid biosynthesis. FAR1 enzyme has been shown to be regulated by levels 
of ether lipids in the cell, indicating the presence of feedback mechanism for ether 
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lipid biosynthesis (Honsho et al., 2010). Ether lipids make up about 20% of total 
phospholipids (Nagan and Zoeller, 2001), and their physiological functions have been 
poorly understood, though progressively, more hints towards their functionality in a 
cell have been uncovered. 
 
Ether lipids could have a role in the trafficking processes in a cell, since synaptic 
vesicles and post-golgi compartments such as the endosomes and the ER have been 
found to be enriched in ether lipids, specifically the PE ether lipids (Breckenridge et 
al., 1973; Honsho et al., 2008; Takamori et al., 2006). Besides, cells defective in ether 
lipid biosynthesis also saw impairment in membrane trafficking, with caveolar 
structures and functions affected, clathrin-mediated processes disrupted and rate of 
endocytosis reduced (Thai et al., 2001). Also, ether lipids have been observed to 
promote membrane fusion due to the inherent nature of the sn-1 vinyl ether chain to 
lower transition temperature between a bilayer and a non-lamellar phase (Glaser and 
Gross, 1994, 1995). Ether lipids have also been implicated in anti-oxidative 
capabilities, with the vinyl ether bond a preferential target for reactive oxygen species, 
hence protecting cells from oxidative stress (Gorgas et al., 2006; Lessig and Fuchs, 
2009). 
 
Cholesterol homeostasis in a cell was also found to be mediated by ether lipids (Munn 
et al., 2003). Munn et al. (2003) reported that specific cholesterol transport pathways 
were affected in cells with defective plasmalogen biosynthesis, affecting mainly the 
transport of cholesterol from the plasma membrane and endocytic compartments to 
the acyl-CoA/cholesterol acyltransferase (ACAT) in the ER (Munn et al., 2003). 
Another study also showed accumulation of free cholesterol in intracellular vesicles 
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which might represent a defect in esterification by ACAT, affecting the recycling of 
cholesterol back to the plasma membrane. On this note, it has been shown that adding 
ether lipid precursors with different carbon chain lengths and saturations to ether 
lipid-deficient cells, affected free cholesterol and cholesterol levels (Mankidy et al., 
2010). Such alterations in cholesterol transport and esterification cause disruptions in 
the balance of cholesterol homeostasis which is important in maintaining membrane 
structure and function in a cell (Field et al., 1998). 
 
Based on our previous experiments observing an enrichment of some ether PCs in 
influenza virus particles and influenza virus-infected A549 cells (our lab’s 
unpublished data), I postulated a role of ether-linked phospholipids in influenza virus 
infection. Many physiological functions have been associated with ether lipids and 
therefore, viruses like influenza virus could potentially exploit the characteristic 
functions of these relatively low abundant phospholipids for life cycle progression. 
For example, trafficking of viral proteins and viral RNA, membrane fusion for entry 
and budding of virus particles are important life cycle stages in an influenza virus 
infection, and ether lipids have been closely associated with these functions as 
highlighted above. Furthermore, since the balance of cholesterol in a cell is crucial for 
budding of viruses, where accumulation of cholesterol will cause rigidity of the 
plasma membrane and prevent budding, while decreased cholesterol will cause 
“leaky” particles which have reduced infectivity (Barman and Nayak, 2007; Rossman 
et al., 2010a), hence, ether lipids could possibly play important roles in maintaining 
cholesterol homeostasis in cells crucial for budding of influenza viruses.  
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1.3 Aims  
All viruses, including influenza viruses, make use of certain host cell factors for 
completion of its life cycle (Hao et al., 2008; Konig et al., 2010), and tailor host cell 
metabolism to their needs (Klemperer, 1961; Munger et al., 2008; Ritter et al., 2010). 
The small genome of influenza virus predisposes the need to exploit host cell 
machinery for efficient virus replication (Coombs et al., 2010), emphasizing the 
importance and potential in targeting host cell factors for antiviral strategies. The 
objective of this study was to understand the functional role of ether lipids in 
influenza virus life cycle, by implementing a comprehensive lipidomics approach 
using mass spectrometry, and hopefully, elucidate the relevance of certain ether lipid 
species during an influenza virus infection. Specifically, this study aimed at: 
1) Establishing lipid changes in influenza virus-infected CHO-K1 wild-type cells 
and their ether lipid-deficient derivatives, NRel-4 cells, in comparison to 
previously established changes in influenza virus-infected A549 cells (our 
lab’s unpublished data). 
 
2) Investigating the relevance of ether lipid species in influenza virus infection 
by siRNA knockdown (KD) technique.
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2 Materials & Methods




2.1 Cells, siRNAs, virus and antibodies 
Chinese hamster ovary-K1 (CHO-K1) cells and its plasmalogen-deficient derivative, 
NRel-4 (Nagan et al., 1998), were obtained from Raphael A. Zoeller (Boston 
University School of Medicine), and cultured in F12 GlutaMax media purchased from 
Invitrogen (Catalogue no. 31765), supplemented with 10% fetal bovine serum (FBS), 
penicillin and streptomycin antibiotics and L-glutamine. Human alveolar 
adenocarcinoma cell line, A549 (CCL-185) were cultured routinely in F12 GlutaMax 
media, supplemented with 10% FBS, penicillin and streptomycin antibiotics and L-
glutamine. Madin-Darby canine kidney, MDCK (CCL-34) cells were routinely 
cultured in DMEM media, supplemented with 10% FBS, penicillin and streptomycin 
antibiotics and L-glutamine. These cells were incubated at 37
o
C and aerated with 5% 
CO2. 
 
Silencer select siRNA targeting the genes of interest (AGPS and Rab11a) were 
purchased from Ambion (Austin, Texas, USA), and two constructs were used for each 
gene of interest. As a control, a scrambled silencer select siRNA was purchased from 
Ambion.  
 
Influenza virus A/PR/8/34 H1N1 virus produced in eggs was propagated in MDCK 
cells, and purified using sucrose gradient according to a previously described protocol 
(Shaw et al., 2008). 
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Antibodies against GAPDH (sc-47724), influenza virus M2 (sc-32238), influenza 
virus NS1 (sc-130568) and α-tubulin were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). Antibody against AGPS (HPA030209) was purchased from 
Sigma Aldrich (St. Louis, MO, USA) and the antibody against Rab11a (ab78337) was 
purchased from Abcam (Cambridge, UK). The goat anti-mouse and goat anti-rabbit 
IgG (H+L)-HRP conjugate secondary antibodies were purchased from Bio-rad 
(Hercules, CA, USA). 
 
2.2 Influenza virus infection 
A549, CHO-K1 or NRel-4 cells were seeded into plates and dishes such that they 
would be confluent for infection with influenza virus after incubating for 24 hrs. The 
cells were washed with serum-free F12 GlutaMax media (supplemented with 
penicillin and streptomycin) twice, and infected with influenza virus at appropriate 
multiplicity of infection (MOI), in serum-free F12 GlutaMax with 0.5µg/ml TPCK 
trypsin. Cells were incubated with virus for 1 hour (hr), and fresh serum-free F12 
GlutaMax media was replaced thereafter. The infected cells were harvested at the 18 
hpi time point, either for lipid profiling using mass spectrometry or for 
immunoblotting. Virus supernatant was collected to determine the titer of virus 
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2.3 Lipid Profiling of influenza virus-infected cells 
2.3.1 Collection of cells 
CHO-K1 and NRel-4 cells were seeded in 10cm cell culture dishes with F12 
GlutaMax media, and infected with H1N1 purified virus at MOI 2 as described above. 
Virus-infected cells and mock-infected cells were collected at 18 hr time point. Three 
replicates were conducted for each condition. To harvest, cells were washed with 
chilled PBS twice, and then scrapped with 500µl chilled methanol. 
 
2.3.2 Lipid extraction 
A modified Bligh and Dyer extraction method (Bligh and Dyer, 1959) was applied. 
To cells that were scraped with 500µl chilled methanol, 250µl of chilled chloroform 
was added to obtain a final ratio of chloroform to methanol 1:2 (volume to volume 
(v/v)). The cells were vortexed at high speed for 1 min, and then incubated on ice for 
1 hr. The tubes were spun briefly and 250µl of chilled chloroform and 275µl of 
chilled milliQ water were added to the samples. The samples were subsequently 
vortexed at high speed for 1 min, and centrifuged at 4
o
C, 10000rpm for 2 mins. The 
lipid containing organic phase was collected and transferred to fresh tubes. The 
aqueous phase was re-extracted with 500µl of chloroform, vortexed again for 1 min 
and spun down at 4
o
C, 10000rpm for 2 mins. Similarly, the organic phase was 
collected, and the samples were vacuum dried using a speed vac (Thermo Savant SPD 
SpeedVac with UVS400A Universal Vacuum System). Samples were stored at -80
 o
C 
before further analysis by mass spectrometry. 
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2.3.3 Quantitative analysis of lipids by HPLC/MS 
Lipids were analyzed as previously described (Shui et al., 2011). Briefly, dried cell 
lipid extracts were dissolved in chloroform to methanol 1:1 and spiked with an 
internal standard mixture consisting of the standards for each lipid class of interest. 
The standards, dimyristoyl-glycero-phosphoserine (DMPS), 1,2-dimyristoyl-glycero-
3-phosphoethanolamine (DMPE), 1,2-dimyristoyl-glycero-3-phosphocholine 
(DMPC), 1,2-dioctanoyl-glycero-3-phosphoinositol (C8PI), lauroyl sphingomyelin 
(L-SM), N-heptadecanoyl-D-erythro-sphingosine (C17 ceramide), and D-glucosyl-ß1-
1'-N-octanoyl-D-erythro-sphingosine (C8 glucosyl ceramide) were obtained from 
Avanti Polar Lipids. These standards were spiked into each sample and measured PS, 
PE and ePE, PC and ePC, PI, SM, and Cer and monohexosyl ceramide 
(MonoHexCer), respectively (Table 1). Subsequently, lipids were separated by high 
performance liquid chromatography (HPLC) using a Luna 3-µm silica column HPLC 
system before introduction into a triple quadrupole instrument ABI 3200QT (Applied 
Biosystems, Foster City, CA). A linear gradient using mobile phase A 
(chloroform:methanol:ammonium hydroxide, 89.5:10:0.5) and mobile phase B 
(chloroform:methanol:ammonium hydroxide:water, 55:39:0.5:5.5) solvent system was 
implemented for HPLC separation. Thereafter, a multiple reaction monitoring 
(MRM)-based approach was employed, where only intensities of known and specified 
ions (based on their mass to charge ratio (m/z)) were measured (Table 2). The PS, PE, 
PI and GM3 species were measured in the negative ion mode while PC, SM, Cer and 
MonoHexCer were analyzed in the positive ion mode.  
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2.3.4 Analysis of MS raw data 
Signal intensities for each lipid species were extracted according to their retention 
time and their concentrations (moles) were calculated by normalization to the 
appropriate internal standard. GM3 levels were normalized with the PI internal 
standard. The lipid molar fractions (the amount of each lipid measured in moles, and 
represented as a fraction of the total) of each sample was acquired by cross 
normalizing the lipid level of each fraction measured (Chan et al., 2008). Data was 
represented as average log-fold ratio of infected cells to mock-infected cells to better 
visualize small changes. Statistical analysis was done using the unpaired Student’s t-
test, identifying significant changes by a two-tailed p-value cut-off < 0.05. 
 
2.4 Effect of ether lipid-deficient cell lines on influenza virus infection – 
Plaque assay & Western blot 
CHO-K1 cells and its plasmalogen-deficient derivative, NRel-4, were infected with 
H1N1 virus and cell lysates and supernatant were collected. Plaque assays was used to 
assess the efficiency of virus release in both cell lines. Also, cell lysates collected 
were used to perform a western blot, to observe changes in viral protein accumulation 
and AGPS protein expression in the infected cells. 
 
2.4.1 Plaque assay to determine virus release 
Plaque assay was conducted as previously described (Matrosovich et al., 2006a). 
Briefly, MDCK cells were grown in 24-well plates, with approximately 2 x 10
5
 cells 
per well. Cells were incubated at 5% CO2, 37
o
C for 24 hrs. The cells were washed in 
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serum-free DMEM media twice and the collected virus supernatant was inoculated 
into the plates in 10-fold dilutions, with 200µl serum-free DMEM media 
supplemented with 1µg/ml TPCK trypsin. The media was replaced with 1ml 2.4% 
Avicel-containing media supplemented with 1µg/ml TPCK trypsin after 1 hr and 
incubated for the next 60 to 80 hrs (Duplicates were done for each dilution). 
Subsequently, the Avicel-containing media was removed from the wells, and 
appropriate volume of 4% formaldehyde was added for 30 mins, removed and washed 
with phosphate buffered saline (PBS) once and then stained using 1% crystal violet in 
20% methanol in water. 
 
2.4.2 Viral protein accumulation observed by Western blot 
Cell lysates were collected at 18 hpi, by washing with PBS twice, and then harvested 
using modified Radio-Immunoprecipitation Assay (RIPA) buffer. Cells were scrapped 
and left in an eppendorf tube for 1 hr on ice, to allow lysing of cells. The cells were 
then centrifuged at 4
o
C, 10000rpm for 10 mins, and the protein lysate contained in the 
supernatant was collected into a separate eppendorf tube. 
 
A modified Lowry’s assay (Biorad, USA) was used to quantify protein 
concentrations, according to the manufacturer’s protocol. Briefly, bovine serum 
albumin (BSA) was used as a standard, and 25µl of Reagent A, an alkaline tartrate 
solution was added to 5µl of sample or standard solution, followed by 200µl of 
Reagent B, a diluted folin solution. Each sample and standard was replicated in three 
wells each. The plate was then kept away from light for about 20 mins, and the 
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intensity read at 750nm absorbance using the microtitre plate reader 
(SpectraMax190).   
 
10µg of each protein sample was run on a 10% SDS-polyacrylamide gel.  
Subsequently, the gel was transferred onto a nitrocellulose membrane using semi-dry 
transfer blotter (Biorad). Then, the membrane was blocked in 5% non-fat milk in 
TBS-T, and the primary antibody was incubated for 2 hrs at room temperature or 
overnight at 4
o
C. Accumulation of virus proteins was assessed either by influenza 
virus M2 antibody or influenza virus NS1 antibody, used at 1:1000 dilution and 1:400 
dilution, respectively. Secondary antibody was incubated for 1 hr at room temperature 
and finally, the membranes were developed using Super signal West Dura 
chemiluminescent from Pierce. The membranes were stripped and reused to blot for 
the loading control α-tubulin or GAPDH. 
 
2.5 siRNA reverse transfection 
siRNA transfection of A549 cells was performed according to the manufacturer’s 
protocol. Briefly, two constructs of siRNA were used for each gene of interest and 
experiments were conducted in duplicates. 200µl of OptiMEM, 6µl of appropriate 
siRNA concentration and 2µl of lipofectamine RNAiMAX reagent (Invitrogen) were 
added to 12-well plates. Subsequently, A549 cells were seeded into each well to 30% 
confluency in F12 GlutaMax media supplemented with FBS, and incubated at 5% 
CO2, 37
o
C for two days. A mock and a negative control (-ve ctrl) transfection was 
also carried out, where RNase-free water and a scrambled siRNA lacking significant 
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sequence homology to the genome, was used respectively. siRNA knockdown 
efficiency and cell viability were validated with real time reverse transcription 
quantitative polymerase chain reaction (RT-qPCR) and MTT cell viability assay 
before an optimal concentration was used to assess the metabolite levels using mass 
spectrometry. Subsequently, the optimal concentration was used also for infection 
experiments. 
 
2.5.1 Validation of siRNA transfection 
2.5.1.1 Real-time PCR 
Cellular RNA was extracted using Qiashredder from Qiagen and RNeasy mini kit 
(Qiagen). The concentration of RNA extracted was quantified using a Nanodrop 
(BioFrontier Technology). Appropriate concentrations of cDNA needed to run the 
RT-qPCR reaction were synthesized using reverse transcription, with the Superscript 
III First-strand synthesis supermix purchased from Invitrogen. The annealing buffer, 
Oligo-dT, 2X first-strand reaction mix and reverse transcriptase enzyme mix were 
used, following the manufacturer’s protocol. Using cDNA as the template, together 
with pre-designed primers targeting the gene of interest and the TaqMan Universal 
PCR Master Mix (Applied Biosystems), qPCR was run using the Realtime 3200 
software. Apart from the primers targeting the gene of interest, an endogenous control 
(18s) and a non-specific primer randomly chosen was also primed for.  
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2.5.1.2 MTT cell viability assay  
A MTT cell viability assay was also conducted to ensure cells were still viable after 
siRNA transfection. The Vybrant MTT cell proliferation assay kit (V13154) was 
purchased from Invitrogen. siRNA was transfected into A549 cells as described 
above, but in a 96-well plate, for 2 days. Cells were then subjected to serum starvation 
(F12 GlutaMax without FBS) for 24 hrs, mimicking infection conditions. After which, 
the cell culture media was replaced with 100µl of fresh F12 media without phenol red 
(Caisson Labs), and 10µl of MTT stock solution was added to each well. The cells 
were incubated at 5% CO2, 37
o
C for 2 hrs, and 85µl of media was removed from the 
wells and replaced with 50µl of dimethyl sulfoxide (DMSO). After incubating for 10 
mins at 5% CO2, 37
o
C, cell viability was assessed by absorbance detection using a 
microtitre plate reader (SpectraMax190), at a wavelength of 540nm. 
 
2.5.1.3 Immunoblotting  
A549 cell lysates were collected, and using the Western blot protocol described 
above, AGPS protein expression was assessed after siRNA transfection. GAPDH was 
blotted as loading control.   
 
2.5.1.4 Lipid profiling of metabolite levels 
Lipids were harvested from cells transfected with siRNA, following the protocol 
mentioned above. Similarly, the extraction protocol, and the analysis of lipids by 
HPLC/MS were conducted as previously described. 
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2.6 Effect of siRNA transfection on influenza virus infection – Plaque 
assay & Western blot 
To determine the effect of siRNA knockdown on influenza virus infection, cell lysates 
and supernatant were collected from cells that were transfected with siRNA and 
subsequently infected with H1N1 virus. Plaque assays following the protocol 
described above were used to assess the efficiency of virus release after siRNA 
transfection. Cell lysates were collected to perform western blots, observing changes 
in viral protein accumulation. 
 
2.7 Rescue of reduced ether lipid levels by addition of metabolites 
Influenza virus-infected AGPS siRNA transfected cells and NRel-4 cells were treated 
with 20µM 1-O-hexadecyl-sn-glycerol (HG) (sc-202394, Santa Cruz biotechnology), 
diluted in 100% ethanol. Control cells containing solely the same final concentration 
of 100% ethanol without HG (Non-treated), were also included in each experiment. 
The infected cells with and without HG treatment were incubated in serum-free F12 
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3.1 Lipid profile of wild-type and ether lipid-deficient CHO cells 
infected with influenza virus  
NRel-4 cells are derivatives of CHO-K1 WT cells, exhibiting decreased DHAPAT 
activity (Nagan et al., 1998), the enzyme required for the first step of ether lipid 
biosynthesis. Therefore, NRel-4 cells were shown to have decreased ether lipid levels 
((Nagan et al., 1998); our lab’s unpublished data).  
 
Mock-infected and H1N1 virus-infected wild-type CHO-K1 and ether lipid-deficient 
CHO cells (NRel-4) were harvested after 18 hpi for lipid analysis using mass 
spectrometry (see Materials and Methods). Three replicates per condition were 
performed and a total of 175 lipid species (Table 2) were analyzed. Significant lipid 
changes in infected cells were calculated based on an unpaired t-test and these 
changes were further compared to previous lipid data established in influenza virus-
infected A549 cells, which identified 68 significant lipid species changes (our lab’s 
unpublished data). 
 
Figure 3.1 illustrates the distribution of significant lipid changes in infected CHO-K1 
WT and NRel-4 cells after 18 hpi. Most of the significant lipid changes belong to the 
PC, GM3 and glucosylceramide (GlcCer) lipid classes, with a handful identified to be 
SM, Cer and other glycerophospholipids like PS, PI and PE species. Intriguingly, 
these infected cells show similar distributions in lipid changes when compared to 
influenza virus-infected A549 cells, as previously established in our lab, with the 
exception of the SM lipid class. More SM lipid species were significantly changed in 
the influenza virus-infected A549 cells, at 18 hpi, and especially at 24 hpi, but since 
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CHO cells are less supportive for influenza virus growth as compared to A549 cells, 
analysis of lipid changes at 18 hpi in CHO cells may not be ideal to capture 
significant changes in SM lipid species.  
 
Using the list of 68 significant lipid species identified in influenza virus-infected 
A549 cells (our lab’s unpublished data), the changes in infected CHO-K1 and NRel-4 
cells were assessed. Figure 3.2 shows a heat plot of the average log (infected/mock-
infected) of the 68 individual lipid species previously identified in A549 infected 
cells, with yellow indicating an up-regulation and blue indicating a down-regulation 
in infected cells. Demonstrated in Figure 3.2, many of the choline containing lipids 
such as PC and SM species differed in infected cells as compared to mock-infected 
cells. Generally, the SM lipid species, which are sphingolipids with a phosphorylated 
choline head group, were up-regulated in infected cells. This finding may be 
supported by published papers identifying the enrichment of sphingolipids in infected 
cells (Gerl et al., 2012), and their importance during an influenza virus infection 
(Simons and Ikonen, 1997). Interestingly, obvious trends between the two subclasses 
of PC species can be distinguished. The ether-linked PCs (ePCs) were predominantly 
up-regulated in A549 and CHO-K1 WT cells, while the ester-linked PCs (aPCs) 
showed a decreasing trend in infected cells. These observations in PC lipid class were 
however, not distinct in NRel-4 cells, indicating the misregulation of ether PCs in 
these cells. Similar changes between the CHO-K1 WT and A549 cells were also 
apparent in Figure 3.3, representing the average log fold ratio of infected and mock-
infected cells for each class of lipids that were previously identified to be significantly 
different in A549 cells (our lab’s unpublished data). Total SM and total ePC lipid 
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classes showed an increasing trend in infected CHO-K1 WT cells, while total GM3 
levels were decreased (Figure 3.3). 
 
Figure 3.1 The number of lipid species in each lipid class that were significantly different 
between infected and mock-infected (A) CHO-K1 cells  and (B) NRel-4 cells.  
Lipid species that were significantly different in infected cells compared to mock-infected cells are 
represented in their respective lipid classes (Indicated in dark grey bars). The choline-containing lipid 
(PC & SM) and sphingolipid (GlcCer and GM3) classes had more proportion of lipids significantly 
changing in (A) CHO-K1 and (B) NRel-4 infected cells. 
  




Figure 3.2 Heat plot of 68 lipid species that were previously identified to change significantly in 
influenza virus-infected A549 cells, and the observed trend in infected CHO-K1 and NRel-4 cells. 
Average log (infected/mock-infected) values of the 68 significant lipid changes previously identified in 
infected A549 cells were plotted on a heat plot, together with observed changes in infected CHO-K1 








Figure 3.3 Lipid classes significantly different in infected and mock-infected cells.  
Significant changes in total lipid class were identified previously in influenza virus-infected A549 
cells. Based on these significantly changed lipid classes, average log (infected/mock-infected) of total 
lipid levels was measured in CHO-K1 and NRel-4 infected cells. Total GM3 levels (B) were reduced in 
all three infected cell lines, and total ePC and total SM levels (A) were increased in A549 and CHO-K1 




Interestingly, there was a general up-regulation of saturated lipid species within most 
of the investigated lipid classes, in infected cells. For example, PS 32:0 is the only PS 
lipid species shown to be significantly up-regulated across all three cell lines. The 
saturated aPC species like PC 34:0a, PC 36:0a and PC 38:0a were also increased in 
infected cells as compared to the other unsaturated PC species, that were either 
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decreased in infected cells or increased only to a lesser extent (Figure 3.2). Similarly, 
the SM and GlcCer species with saturation both at the sphingosine backbone and at 
the fatty acid chain (eg, SM d18:0/22:0, SM d18:0/26:0, GlcCer d18:0/22:0) were also 
slightly more up-regulated in infected cells relative to the unsaturated species and the 
species with only one saturation at either the sphingosine backbone or fatty acid 
chain, but not both (Figure 3.2).  
 
For the purpose of this project, I decided to focus on choline containing lipids, 
especially PC, due to their importance in influenza virus infection (Kawasaki and 
Ohnishi, 1992) and due to the consistency in trend, observed in infected CHO-K1 and 
A549 cells, and in purified influenza virus particles (H3N2 and H1N1). In these 
purified viruses, it was found that aPCs were decreased while the ePCs were 
unchanged or enriched as compared to the host cell plasma membrane ((Gerl et al., 
2012); our lab’s unpublished data). The analysis of PC species in infected and mock-
infected cells also displayed a strong and distinct trend. aPCs were generally down-
regulated in CHO-K1 infected cells, except for the saturated and very long chain poly-
unsaturated species that were up-regulated, such as PC 34:0a, PC 36:0a and PC 38:6a 
(Figure 3.2). ePCs on the other hand, were largely up-regulated in CHO-K1 infected 
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3.2 Ether lipid-deficient cell line, NRel-4 affects influenza virus 
infection  
With the interest to understand why there is a specific increase in the ePCs and not 
aPCs in influenza virus-infected A549 cells and CHO-K1 cells, the effect of ether 
lipid deficiency on influenza virus infection was determined. Both CHO-K1 WT and 
NRel-4 cells were infected with influenza H1N1 virus, and the virus titer produced 
was evaluated by plaque assay. Three independent experiments were conducted, with 
replicates for each cell type. A phenotypic effect on influenza virus infection was 
evident, illustrated by a 70 to 80% decrease in the average percentage (%) plaque 
formation in NRel-4 cells as compared to the CHO-K1 WT cells (Figure 3.4A). 
Western blot analysis also detected a decrease in influenza virus M2 protein and 
influenza NS1 protein in the NRel-4 mutant cells (Figure 3.4B). These results 
emphasize the possible role of ether lipids in an influenza virus infection. 
 
 
Figure 3.4 NRel-4 cells showed decreased virus titer and viral protein expression compared to 
CHO-K1 WT cells. 
CHO-K1 WT and ether lipid-deficient NRel-4 cells were infected with H1N1 influenza virus and their 
virus titer and viral protein levels were assessed by plaque assay (A) and western blot (B) respectively. 
NRel-4 cells had a 70 to 80% decrease in plaque formation (n=3) (unpaired Student’s t-test; two-tailed; 
p<0.005), and a decrease in both influenza M2 and NS1 proteins, as seen in (B). GAPDH was used as a 
loading control. 
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3.3 AGPS knockdown using siRNA changes ether lipid levels in A549 
cells. 
With the observation of a decreased influenza virus infection in ether lipid-deficient 
CHO cell lines, it would be interesting to further investigate if downstream targets of 
the ether lipid biosynthesis pathway would also affect influenza virus infection. For 
this interest, siRNA technique was applied to knockdown AGPS, the second step of 
ether lipid biosynthesis, in A549 cells, and the knockdown effect on influenza virus 
infection was assessed. 
 
Utilizing siRNA technique to knockdown genes of interest required careful 
consideration of a few factors. An optimization process was carried out to ensure 
sufficient knockdown efficiency on the genes of interest, and at the same time, not 
compromising on the cell viability. For this purpose, knockdown experiments were 
carried out with two constructs per gene of interest, using a series of siRNA 
concentrations. The specificity of siRNA knockdown was briefly examined by 
randomly probing for another primer other than the gene of interest. The purchased 
siRNAs have been validated as stated by the manufacturer and hence, validation of 
off-target effects was beyond the scope of this study. The knockdown efficiency was 
validated using RT-qPCR, to assess the gene expression levels, and MTT cell viability 
assay was conducted to ensure that cell viability was not affected during gene 
knockdown. Further experiments to assess the AGPS knockdown phenotype were 
also conducted, checking for protein expression and metabolite levels of the targeted 
gene of interest, using western blots and mass spectrometry respectively.  
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3.3.1 AGPS siRNA treatment reduced AGPS gene expression levels, without 
compromising cell viability 
AGPS knockdown experiments were carried out using s16248 and s16249 constructs, 
at three concentrations of siRNA, 12nM, 6nM and 3nM, and following a 48 hr reverse 
transfection protocol described in Materials and Methods. Figure 3.5 compiles the 
average percentage of AGPS gene expression relative to the –ve ctrl, which is a 
scrambled siRNA sequence that lacks sequence complementarities to the gene of 
interest. The AGPS knockdown efficiency experiment was repeated three times, and a 
significant difference was identified using an unpaired t-test; two-tailed. As seen from 
Figure 3.5, both constructs s16248 and s16249, at all three concentrations, generally 
resulted in a significant reduction (p<0.005) of AGPS gene expression levels to about 
2% to 10%, indicating a successful gene knockdown. Phosphoglycerate kinase 
(PGK), an enzyme involved in the glycolytic pathway, is moderately related to AGPS, 
and hence was selected as a primer to assess the specificity of AGPS siRNA. Table 3 
included in the appendix, indicates the % knockdown efficiency (from which the 
average % of AGPS gene expression in Figure 3.5 was derived) and % off-target 
effects observed in each of the three independent experiments. The off-target effects 
were mostly insignificant, with the gene expression of PGK either slightly reduced 
(<20%) or still largely present in the cells with a 1 to 2 fold up-regulation, after AGPS 
siRNA treatment.  
 




Figure 3.5 AGPS gene expression levels decreased after siRNA treatment.  
A549 cells transfected with AGPS siRNA constructs, s16248 and s16249 at 12nM, 6nM and 3nM 
concentrations had significant knockdown effects relative to cells transfected with a scrambled -ve ctrl 
siRNA; unpaired Student’s t-test was used to calculate statisitical significance (* indicates two-tailed p-
value<0.005). AGPS gene expression was reduced to 10% or less in AGPS siRNA transfected cells. 
AGPS siRNA s16248 was a better knockdown construct, with greater reduction of AGPS gene 
expression in all three concentrations used. 
 
Cell viability was assessed with MTT assay, after 48 hr transfection with AGPS 
siRNA. The viability assay was performed in three independent experiments, and the 
average percentage cell viability, and standard deviation was compiled in Figure 3.6. 
A549 cells were between 80 to 100% viable after 3nM to 12nM AGPS siRNA 
treatment, relative to the –ve ctrl (Figure 3.6). An unpaired Student’s t-test was 
conducted to test for significant change in cell viability, and it was verified that cell 
viability was not significantly compromised after AGPS knockdown.   
 




Figure 3.6 A549 cells were viable after AGPS siRNA knockdown.  
MTT cell viability assay was conducted after A549 cells were transfected with AGPS siRNA for 48 
hrs. AGPS siRNA constructs, s16248 and s16249 at 12nM, 6nM and 3nM concentrations had 80 to 
100% of the cells still viable, relative to the –ve ctrl siRNA treated cells. 
 
Other phenotypic changes were evaluated to ensure that AGPS protein levels were 
successfully depleted with reduced metabolite levels. Western blot and mass 
spectrometry were performed on AGPS knockdown cells to ascertain AGPS protein 




3.3.2 AGPS siRNA treatment successfully reduced AGPS protein expression 
Cell lysates were collected from A549 cells that were transfected with 12nM s16248 
and s16249 AGPS siRNA, and the AGPS protein levels were assessed by Western 
blot. It was evident that AGPS protein expression was successfully depleted after 
AGPS knockdown from both constructs, as compared to the water (H2O) or –ve ctrl 
transfected cells.  





Figure 3.7 AGPS protein expression decreased after AGPS siRNA knockdown 
AGPS protein expression was greatly reduced after A549 cells were transfected with 12nM s16248 and 
s16249 AGPS siRNA, as compared to cells that were transfected with water and –ve ctrl siRNA. 
GAPDH was used as a loading control.  
  
3.3.3 AGPS siRNA treatment reduced ether lipid levels 
Lipids were extracted from cell lysates that were transfected with 12nM of s16248 
and s16249 AGPS siRNA, following the protocol mentioned. The lipid profiles (two 
independent experiments performed in triplicates per condition) of AGPS transfected 
cells were similar to those of the –ve ctrl transfected cells, when analyzed at lipid 
class levels.  
 
PE and PC lipids were analyzed by individual lipid species, and it was identified that 
ePE and ePC lipid species were significantly down-regulated in AGPS knockdown 
cells, while the ester-linked PE (aPE) and aPC lipid species were mainly up-regulated 
(Figure 6.1). When taken together, a significant reduction was observed in total ether 
PE and PC lipids (Figure 3.8B), while total ester PE and PC lipids were significantly 
increased (Figure 3.8A), in cells transfected with AGPS siRNA (n=2). The significant 
difference was identified using an unpaired Student’s t-test (two-tailed;p<0.05). ePC 
to aPC ratio was plotted and it was evident that the ePC to aPC ratio decreased in 
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AGPS s16248 and s16249 transfected cells, compared to the –ve ctrl transfected cells 
(Figure 3.9). 
 
To further illustrate the extent of AGPS knockdown on specific ether and ester PE and 
PC lipid species, PE and PC lipid species that were significantly different in the 
AGPS knockdown cells were identified based on two criteria: 1) the lipid species 
were significantly different (unpaired Student’s t-test; two-tailed; p<0.05 in at least 
one siRNA knockdown construct as compared to the –ve ctrl, and 2) same trend was 
observed in both constructs. The average log (AGPS knockdown/-ve ctrl) values were 
then plotted. Figure 6.1 shows the significant PE and PC species identified from both 
experiments (A) and (B), and it is evident that ether-linked lipids from both PE and 
PC classes were largely down-regulated, and ester-linked lipid species were generally 
up-regulated in AGPS knockdown cells. Therefore, it can be concluded that AGPS 
siRNA transfected cells do display a reduction in ether lipid levels, indicating that 
AGPS knockdown is not just on a protein expression level, but also impacts 
metabolite levels. The alteration of ether lipid levels, without much changes to other 
lipid classes allowed the use of siRNA technique to further investigate the role of 








Figure 3.8 Total ester and ether lipids after AGPS siRNA knockdown.   
Total ester PE and PC lipids (A) were significantly increased while the total ether PE and PC lipids 
were significantly decreased (B), in both constructs of AGPS transfected cells (n=2); unpaired 
Student’s t-test; two-tailed; *** indicates p<0.001; ** indicates p<0.01; * indicates p<0.02.  
 




Figure 3.9 ePC/aPC ratio decreased in AGPS knockdown cells. 
ePC to aPC ratio in –ve ctrl, AGPS s16248 and AGPS s16249 transfected cells were represented in a 
plot. In both experiments conducted (denoted by ♦ and ◊), there is a decrease of ePC to aPC ratio in 
both AGPS knockdown constructs as compared to the –ve ctrl transfected cells.  
 
3.3.4 Effect of AGPS knockdown on influenza virus infection 
ePCs and not aPCs were up-regulated during influenza virus infection. Besides 
observing a reduced virus infection in ether lipid-deficient NRel-4 cells, the effect of 
decreased ether lipid levels on influenza virus infection was also assessed by siRNA 
knockdown of AGPS. After siRNA transfection, A549 cells were infected with 
purified H1N1 virus at MOI 1-2. Virus titer after 18 hpi was determined by plaque 
assay. AGPS knockdown cells had a significant reduction in plaque formation (Figure 
3.10A) as compared to  –ve ctrl siRNA(unpaired Student’s t-test; two-tailed p< 0.01). 
This significant reduction in plaque formation was similarly observed using a Rab11a 
siRNA construct (Figure 3.10A), (unpaired Student’s t-test; two-tailed; p-value 
<0.02). Rab11a siRNA was selected to act as a positive control, since it has been 
previously reported that Rab11a is crucial for various stages of influenza virus life 
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cycle. Rab11a has been found to be required for cytoplasmic transport of vRNP to the 
plasma membrane (Amorim et al., 2011; Eisfeld et al., 2011), and also for budding of 
influenza virus particles (Bruce et al., 2010). The knockdown efficiency of Rab11a 
siRNA s16703 and s16704 constructs were validated by RT-qPCR (Table 4), 
immunoblotting (Figure 6.2) and MTT assay (Figure 6.3) for gene expression, protein 
expression levels and cell viability respectively. It was verified that both constructs of 
Rab11a siRNA had high knockdown efficiency and cell viability, hence, the s16703 
construct was randomly picked as a positive control in all subsequent experiments.   
 
The decrease in percentage plaque formation suggests that virus titer, and/or the 
infectivity of the virus particles produced was affected in both AGPS and Rab11a 
knockdown cells. Assessing the viral protein expression levels by western blot was 
crucial to identify if AGPS and Rab11a knockdown resulted in a change in the 
replication of viral proteins (i.e, M2), or instead, affected stages after virus replication 
(i.e, budding and re-entry). Detection of influenza virus M2 protein saw no change in 
AGPS knockdown and Rab11a knockdown cells, as compared to the –ve ctrl (Figure 
3.10B). The α-tubulin antibody was probed to ensure equal loading. Figure 3.10 only 
includes western blot results from one infection experiment, and the rest of the 
replicates (n=3), have similar observations (Figure 6.4). 





Figure 3.10 Virus titer and viral protein expression levels after AGPS and Rab11a siRNA 
knockdown. 
Average % plaque formation (n=3) shows a 60 to 70% decrease in virus titer in AGPS and Rab11a 
knockdown cells relative to the –ve ctrl transfected cells (A)(unpaired Student’s t-test; two-tailed; * 
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4.1 Insights from lipid profile of infected cells 
Lipid profiling of infected and mock-infected cells have allowed us to identify 
interesting trends in host cells during an influenza virus infection, providing 
conjectures on how certain lipids could play a role in infection. Based on our previous 
observation that ePCs were increased and aPCs were decreased in influenza virus-
infected A549 cells (our lab’s unpublished data), an important role of ether lipids 
during influenza virus life cycle can be postulated. Hence, an ether lipid-deficient 
CHO cell line was used to assess the impact on influenza virus replication. However, 
to confirm the observed changes in infected A549 cells, and to see if such lipid 
changes hold true for a different cell line, the lipid profile of infected CHO-K1 WT 
cells were first established. From our study, it was thus shown that similar trends and 
lipid changes were observed in infected A549 and CHO-K1 WT cells. 
 
4.1.1 The decrease in GM3 possibly reflects neuraminidase activity 
Despite evidence showing an importance of GSL biosynthesis during the late stage of 
influenza virus infection (Hidari et al., 2006), interestingly, an obvious decrease in the 
GM3 lipid species was observed in infected cells (Figure 3.2 and Figure 3.3). This 
could be due to the presence of NA activity in infected cells. NA releases virus 
progeny from host cell surface, by cleaving off the binding between the virus and 
sialic acid modified glycoproteins and lipids (Sato et al., 1996). Since GM3 is a 
glycosphingolipid containing an external sialic acid (Matrosovich et al., 2006b), NA 
activity during an infection could hydrolyze GM3, resulting in a degradation of GM3. 
It has been reported that the NA protein of influenza virus PR/8/34 (H1N1), which is 
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the virus strain used in this study, and influenza virus Aichi/2/68 (H3N2) are able to 
hydrolyze GM3 (Sato et al., 1998). Hence, the observed decrease in the GM3 lipids in 
infected cells could be an effect of degradation of GM3, and not an impairment of 
biosynthesis or metabolism involving GM3 lipids. Furthermore, the recent influenza 
virus lipid profile conducted by Gerl et al. (2012) also showed the absence of GM3 in 
the virus envelope, which they explained by the presence of NA activity (Gerl et al., 
2012). 
 
Hence, the decrease in GM3 could also be functionally important for an influenza 
virus infection. It has been reported that increasing ganglioside sialidase (i.e. NA) 
activity could lead to a greater production of ceramides in the plasma membrane, by 
removal of the sugar unit from ganglioside GM3 (Valaperta et al., 2006). Ceramide 
has been known to play key roles in various cell signalling processes, including cell 
proliferation and apoptosis (Obeid and Hannun, 1995), and it is also widely associated 
with the sphingomyelin cycle which involves activity of sphingomyelinase and 
sphingomyelin synthase (Valaperta et al., 2006).  It can be postulated that the decrease 
in GM3 is a mechanism utilized by influenza virus particles to increase the pool of 
ceramide, and to tap on the diverse signalling capacities of the ceramide lipid class. 
Besides, it was identified that an increase in ceramide production from GM3 
hydrolysis results also in an increase in sphingomyelin (Valaperta et al., 2006), and 
similarly, coupled to an obvious decrease in GM3 lipids, an increase in 
sphingomyelins was observed (Figure 3.2). This highlights a possible cross-talk 
between sphingomyelins and ceramides using GM3 as a mediator, during influenza 
virus infection.     
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4.1.2 Sphingomyelin species are increased in infected cells: Possible 
implications for virus budding and particle functionality 
Sphingomyelin species were up-regulated in influenza virus-infected CHO-K1 and 
A549 cells (Figure 3.2; Figure 3.3). This is in line with the recent study conducted by 
Gerl et al. (2012), showing that the enrichment of sphingolipids and cholesterol were 
observed in the host apical membrane, the site of influenza virus budding, and further 
enrichment was found in the virus membrane (Gerl et al., 2012). These sphingolipid 
and cholesterol enriched microdomains are required in transport, assembly and 
budding of influenza virus particles, and many influenza viral proteins especially HA 
are reportedly associated with these microdomains (Veit and Thaa, 2011). In addition, 
it was identified that sphingolipids, though may not directly affect membrane fusion 
like cholesterol, acts as a supporting role and can affect the efficiency of membrane 
fusion (Rogasevskaia and Coorssen, 2006). Hence, the up-regulation of sphingolipids 
observed in influenza virus-infected cells might be induced for the formation of these 
microdomains, for the purpose of final stages of influenza virus life cycle completion, 
and also for membrane fusion during virus entry into host cells. 
 
4.1.2.1 The up-regulation of saturated, long chain lipids might be implicated in the 
remodelling of functional ordered domains 
Scutinizing the lipid changes in terms of saturation and chain length of the fatty acyl 
chains revealed interesting trends. Saturated lipid species, including those belonging 
to the SM and GlcCer lipid classes, were slightly up-regulated in infected cells, with a 
more obvious trend observed in infected A549 cells (Figure 3.2). This trend may be 
less prominent in CHO-K1 cells possibly because CHO-K1 cells are less supportive 
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for influenza virus growth as compared to A549 cells, hence, the analysis of lipids of 
CHO-K1 infected cells only at 18 hpi may not be sufficient to observe significant 
changes in certain lipid species. Nonetheless, this observation was attested by Gerl et 
al. (2012), since they also reported an increase in saturated and longer chain 
sphingolipids (≥36 carbon atoms) in the apical membranes of MDCK cells (Gerl et 
al., 2012). Taken together, these observations could hint towards the importance of 
such lipids for efficient virus release and infection. Studies have identified an 
organization of membranes consisting of sphingolipids and cholesterol (Simons and 
Ikonen, 1997), also known as lipid rafts, that play roles in signal transduction and 
membrane fusion in cells (Deborah, 1993; Simons and Ikonen, 1997). Essentially, 
these are detergent-insoluble glycolipid rich complexes (DIGs) composed of 
glycosphingolipids and lipids with long saturated acyl chains, and cholesterol 
embedded within (Scheiffele et al., 1995). Transmembrane HA protein of influenza 
virus is found to be associated with these DIG domains (Fiedler et al., 1993), and the 
saturated fatty acids and acylation of HA are suggested to be key players in these 
interactions (Melkonian et al., 1999; Wagner et al., 2005). Furthermore, these HA 
clusters associated with DIGs are found to be assimilated into virus particles 
(Scheiffele et al., 1999; Zhang et al., 2000), and are crucial for efficient viral fusion 
(Takeda et al., 2003). Polozov et al. (2008) also suggested that influenza virus 
envelope is not derived entirely from a lipid ordered domain. Instead, palmitoylation 
of HA protein occurs to serve as a lipid anchor, assembling other saturated lipids and 
cholesterol to the plasma membrane, and preparing the virus envelope for increased 
stability that is critical during air borne transmission (Polozov et al., 2008). Hence, all 
these evidences might corroborate a crucial role of saturated lipid species in 
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maintaining a functionally important ordered domain for successful completion of an 
influenza virus life cycle.  
 
In addition, the observed increase in saturated and long chain sphingolipids could also 
be important for membrane fusion during virus entry into host cells. Early studies 
reported that the addition of saturated acyl chain fatty acids to cell culture media was 
able to induce viral fusion, but lead to an inhibition of polyethylene glycol (PEG)-
induced fusion, since cell susceptibility to viral fusion and PEG-induced fusion is 
inversely correlated (Roos et al., 1990). In this paper, it was also identified that 
fusion-altered cell lines favouring viral fusion rather than PEG-induced fusion, had a 
unique lipid composition with elevated saturated fatty acids and the presence of an 
unusual ether-linked neutral lipid (Roos et al., 1990). These findings might suggest 
that infected cells have a preference for saturated lipid species to cope with membrane 
fusion functions that occur during an influenza virus life cycle.  
 
However, this proposed mechanism still needs to be elucidated, since Kawasaki and 
Ohnishi (1992) offers a differing opinion that unsaturated acyl chains of the PC lipid 
species may be crucial for fusion to occur, since it curves more easily and favours a 
membrane fusion (Kawasaki and Ohnishi, 1992). Controversial findings were also 
reported on the role of acylation, where studies identified that acylation of HA, has no 
effect on fusion activity (Naim et al., 1992; Steinhauer et al., 1991; Veit et al., 1991).  
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4.1.3 Ether lipids, specifically ether PCs could play key roles in influenza virus 
infection 
Another intriguing observation from the lipid profile of infected CHO-K1 cells and 
the previously established lipid profile of infected A549 cells (our lab’s unpublished 
data) was the increase specifically in ePC species and a decrease in most of the aPC 
species, except the saturated and long chain species (Figure 3.2; Figure 3.3). The 
inversed trend between ePC and aPC at 18 hpi was sufficient to intrigue interest in the 
role of ether lipids in influenza virus infection. Besides, an increase in ePC/aPC ratio 
was also identified in influenza A virus particles ((Gerl et al., 2012); our lab’s 
unpublished data). Hence, functional experiments were conducted to further elucidate 
the importance of ether lipids in influenza virus life cycle.   
 
4.2 Host cell ether lipids in influenza virus infection 
4.2.1 Ether lipid-deficient cell line, NRel-4 significantly impaired influenza 
virus infection 
Ether lipid-deficient CHO cells, NRel-4, were first used to validate if ether lipids are 
crucial during an influenza virus infection. NRel-4 cells are deficient in DHAPAT, the 
first step in ether lipid biosynthesis (Figure 4.1), and hence, resulting in a deficiency 
in ether lipids (Nagan et al., 1998). Other components of the ether lipid biosynthetic 
pathway were found to be normal in NRel-4 cells, and they were reported to contain 
functional and intact peroxisomes (Nagan et al., 1998). Similarly, there was no change 
in AGPS protein expression (second step of ether lipid biosynthesis) in NRel-4 cell 
lines, compared to the CHO-K1 WT cells (Figure 3.4B). Hence, DHAPAT inactivity 
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is the only cause for the deficiency of ether lipids in these NRel-4 cells. NRel-4 cells 
had a 70 to 80% reduction in virus titer, and a decreased influenza virus M2 protein 
and NS1 protein expression compared to the CHO-K1 WT cells (Figure 3.4). This 
suggests that ether lipid deficiency due to the defect of DHAPAT enzyme, has an 
effect on influenza virus infection. Further studies were conducted to investigate if 
this observed phenotype on virus infectivity was associated only with DHAPAT 
inactivity, or similar reduction downstream of ether lipid biosynthesis could also 
affect influenza virus infection. 
  




Figure 4.1 Ether lipid biosynthesis pathway 
Ether lipid biosynthesis branches off from the glycolytic pathway, using glycerone phosphate (DHAP) as a substrate. DHAPAT functions to esterify DHAP, and AGPS forms 
the ether bond by attaching a long chain fatty alchohol. 
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4.2.2 siRNA knockdown of AGPS observed reduction in influenza virus 
infection 
For this purpose, a siRNA knockdown technique targetting AGPS, the second step of 
ether lipid biosynthesis (Figure 4.1), was harnessed. There was a significant decrease 
in virus titer produced in these AGPS knockdown cells, relative to the –ve ctrl 
knockdown cells (Figure 3.10A).  
 
A positive control using Rab11a siRNA knockdown was also conducted on A549 
cells. Rab proteins are small GTP-binding proteins ascertained to play many roles in 
intracellular trafficking from docking and tethering, to motility of vesicles from one 
organelle to another (Zerial and McBride, 2001). Rab11a is one of the Rab proteins 
involved in the regulation of trafficking between the trans-Golgi network, recycling 
endosome and the plasma membrane (Chen et al., 1998; Ullrich et al., 1996; Urbe et 
al., 1993). The association of Rab11a with influenza virus is evident, with studies 
demonstrating the need for Rab11a proteins in cytoplasmic transport of vRNP to the 
plasma membrane. Abrogation of this protein caused intracellular accumulation of 
vRNP (Amorim et al., 2011; Eisfeld et al., 2011). Depletion of Rab11a protein also 
resulted in a decrease in influenza virus titer released from cells, by interfering with 
the final budding step involved in the formation of filamentous virions (Bruce et al., 
2010). Bruce et al. (2010) observed a 90% reduction of influenza virus titer with 
depletion of Rab11a, and it was hypothesized that Rab11a functions as a mediator to 
recruit cellular mechanisms required for membrane scission (Bruce et al., 2010). This 
hypothesis was derived since yeast Rab11 homologues, Ypt31 and Ypt32 were shown 
to mediate exocytotic trafficking from the Golgi, most probably through membrane 
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scission (Benli et al., 1996). Similarly, I observed an approximate 60% reduction in 
virus titer in Rab11a siRNA transfected cells (Figure 3.10A). With Rab11a 
knockdown cells as a positive control, it can be verified that AGPS knockdown cells 
also observed similar reduction in virus titer, attesting that AGPS is crucial for 
influenza virus infection.  
 
Putting together the observation of DHAPAT impaired NRel-4 cells and AGPS 
depleted A549 cells, it is evident that ether lipid deficiency causes a reduction in virus 
titer production, as observed in the plaque assays conducted. However, differences in 
viral protein accumulation was observed between NRel-4 cells and AGPS knockdown 
A549 cells. NRel-4 cells showed a reduction in M2 viral protein accumulation (Figure 
3.4B), but this was not observed in AGPS knockdown A549 cells (Figure 3.10B). 
This could be due to differences in the accumulation of lipid intermediates in both cell 
lines. NRel-4 cells with inactivity of DHAPAT enzyme would result in the 
accumulation of glycerone phosphate, a lipid intermediate that is more upstream of 
ether lipid biosynthesis, and also a substrate for the biosynthesis of other glycerol 
lipids like diacylglycerol (DAG) and triacylglycerol (TAG). Inactivity of DHAPAT 
therefore may have more drastic impact on the host cell’s lipid metabolism, hence, 
possibly affecting also the replication of viral proteins during influenza virus 
infection. Besides, another possible explanation could be because ether lipids were 
depleted to a larger extent in the NRel-4 cells, compared to the AGPS siRNA 
knockdown cells, hence the observed difference was more striking in the ether lipid 
deficient cells as additionally observed in a stronger reduction of infectious virus 
particles. It is also important to note that the CHO-K1 and NRel-4 cells were not 
homogenous cell lines.       




4.2.3 The up-regulation of ePCs might be hypothetically linked to an important 
role in influenza virus life cycle 
Summarizing the findings, an increase specifically in ether PCs was observed during 
influenza virus infection, and interfering with the metabolism of ether lipids (ether 
lipid-deficient NRel-4 cells and AGPS knockdown A549 cells) impaired influenza 
virus replication. Based on these findings, I postulate that ePC lipids could play 
important roles in influenza virus infection. Evaluating functional roles of ether 
phospholipids from literature and identifying their possible association with influenza 
virus life cycle stages, I hypothesized some of the possible roles of ether lipids in 
various influenza virus life cycle stages, which are summarized below. 
 
4.2.3.1 A possible role of ether lipids in influenza virus trafficking, assembly and 
budding 
Firstly, the hypothesis was based on the findings that trafficking organelles such as 
the synaptic vesicles (Takamori et al., 2006) and secretory granules (Bjerrum et al., 
1989) are enriched in ether lipids. Trafficking vesicles require the organized 
recruitment of protein complexes from the cytoplasm for functional purposes in 
transport, docking and fusion, and the membrane constitution of the vesicles are 
important for the association and disassociation with these proteins (Takamori et al., 
2006). Hence, the presence of ether lipids in these trafficking vesicles may suggest an 
important role of ether lipids in the execution of trafficking functions. Besides, the 
complexity of the composition and constitution of trafficking vesicles like that of the 
synaptic vesicles are comparable to that of viruses (Takamori et al., 2006), indicating 
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also the functional role that ether lipids could have in virus particles. The hypothesis 
associating ether lipids with trafficking and assembly processes of influenza virus 
infection was further emphasized when Thai et al. (2001) revealed that ether lipid-
deficient cells had multiple defects in the transport pathways, observing structural 
changes such as dilation of ER and Golgi cisternae, and also a decrease in the rate of 
endocytosis (Thai et al., 2001). The dilation of ER and Golgi cisternae in ether lipid-
deficient cells are indicative of an impairment in the secretory pathway from the 
trans-Golgi network (Thai et al., 2001), hence reiterating that ether lipids might be 
important for the trafficking of viral proteins and RNA components from Golgi to the 
plasma membrane. Evidently, Munn et al. (2003) also saw a 30% reduction of protein 
secretion in ether lipid-deficient cells (Munn et al., 2003).    
 
Ether lipid-deficient cells with mutation in the DHAPAT and AGPS enzymes have 
also been found to mediate cholesterol homeostasis (Munn et al., 2003). These mutant 
cells decrease the availability of cholesterol for efflux, affecting the cellular 
distribution of cholesterol in cells (Munn et al., 2003), possibly also disrupting the 
accumulation of cholesterol at the plasma membrane. The role of ether lipids in 
mediating cholesterol homeostasis in cells is probably important in the influenza virus 
budding process, since influenza virus particles require very precise cholesterol 
balance in the plasma membrane for efficient budding. It has been reported that 
disruption of cholesterol balance in cells by methyl-beta-cyclodextrin treatment 
results in an increase in the production of virus particles, but a reduction in the 
infectivity of virus particles (Barman and Nayak, 2007; Sun and Whittaker, 2003). On 
the other hand, the addition of exogenous cholesterol results in decreased budding 
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(Barman and Nayak, 2007). Virus particles produced derive their viral envelope from 
the plasma membrane, and sufficient cholesterol accumulation is required to produce 
virus particles with “non-leaky” and well-integrated viral proteins. However, an over-
accumulation of cholesterol could result in rigid membrane structure that impairs the 
membrane bending required during budding (Polozov et al., 2008). Hence, there is 
possibly a tight regulation of cholesterol metabolism crucial for influenza virus 
infection, and ether lipids could be playing an indirect role in regulating this 
cholesterol balance.  
 
Besides, influenza M2 protein has been found to be recruited to the budding site to 
assist membrane bending and finally cause a membrane scission that allows the 
release of new virus progeny (Chen et al., 2008; Rossman and Lamb, 2011). 
Depleting M2 proteins have resulted in an inhibition of virus budding, though not the 
initiation of bud formation (Chen et al., 2008; Rossman et al., 2010b; Rossman and 
Lamb, 2011). The M2-mediated membrane scission is proposed to involve also the 
binding of cholesterol to M2 proteins, where binding of cholesterol have been 
recognized to affect the ability of amphiphatic helixes to modulate membrane 
curvature (Egashira et al., 2002; Rossman et al., 2010a). Hence, this affirms the 
importance of the role of cholesterol in mediating filament formation and budding 
processes of influenza virus infection, and therefore, implicating the indirect role of 
ether lipids in mediating these influenza virus life cycle processes. The fusogenic 
properties of ether lipids with the propensity to form non-lamellar structures also 
accentuate the potential role they play in membrane fusion and budding processes 
(Gorgas et al., 2006), at initial and later stages of infection.   
 
4. Discussion  
 
68 
4.2.3.2 The up-regulation of ether lipids could be indirectly linked to an increase in 
glycolysis in infected cells 
An indirect association between the lipid biosynthesis and the glycolytic metabolism 
of the host cell during an influenza virus infection could be drawn. Firstly, it is well 
established that in many virus studies, including influenza virus infections, host cell 
metabolism is greatly altered (Ritter et al., 2010). It has been identified that an 
increased glycolytic flux during HCMV infection is correlated with an efflux into the 
fatty acid biosynthesis pathway, and increased synthesis of the tricarboxylic acid 
(TCA)-related amino acids (Munger et al., 2008). An association between glycolytic 
flux and lipid metabolism is further highlighted, since proliferating cancers with high 
aerobic glycolysis is also known to have high flux in marcromolecular biosynthesis, 
TCA and lipid biosynthesis (DeBerardinis et al., 2008).  
 
During influenza virus infections, Klemperer (1961) has reported that the glycolytic 
pathway and pentose phosphate pathway are greatly induced upon early stages of 
infection (Klemperer, 1961). It was proposed that elevation of glycolytic flux was 
essential for the production of energy for RNA, DNA and macromolecule synthesis 
during an infection (Klemperer, 1961). However, this postulation can be contested 
since metabolic flux analysis conducted by Ritter et al. (2010) indicated that the 
increase in glycolytic flux occurs only approximately 12 hpi, and Ritter et al. (2010) 
attributed this increase to the onset of apoptosis (Ritter et al., 2010). The claim made 
by Klemperer (1961) is further refuted, since it has been shown that only 2% of the 
normal ATP turnover was sufficient to fulfill energy requirements during an influenza 
virus infection (Ritter et al., 2010). Besides, studies also reported that virus replication 
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will not affect much of the ATP balance in host cells, and similarly, availability of 
ATP is not a limitation of virus replication (Genzel et al., 2007; Sidorenko and Reichl, 
2004). Despite reported differences in the onset of metabolic flux and differences in 
the proposed mechanism of action by the influenza virus, it can be concluded that 
glycolytic flux is important during an infection, however, differences in metabolic 
changes could also depend on cell lines and virus strains used.  
 
It is postulated that the up-regulation of ether lipids observed in influenza virus 
infected cells (Figure 3.2; Figure 3.3) is indirectly associated with the glycolytic flux 
that occurs during an influenza virus infection. Ritter et al. (2010) observed that the 
upper part of the glycolytic pathway was greatly increased in influenza virus-infected 
cells, 12 hpi, and glycolytic intermediates downstream of the glycolytic pathway had 
a lower increase or a decrease in infected cells (Ritter et al., 2010). Much higher 
increase in the glycolytic intermediates were observed upstream of the fructose-1,6-
biphosphate (F16BP) intermediate, and the intermediates downstream are either less 
increased in infected cells, or are decreased. Incidentally, the glycolytic pathway after 
F16BP is channelled either to glyceraldehyde-3-phosphate to continue with 
glycolysis, or is directed to form glycerone phosphate, a substrate for ether lipid 
biosynthesis (Figure 4.1). This could indicate that there was a shift in host cell 
metabolism, away from glycolysis and channelled towards ether lipids biosynthesis, 
hence the evidence of ether lipid up-regulation observed in this study. Intriguingly, it 
was also observed that in a proteomic study conducted by Shaw et al. (2008), host cell 
proteins were identified in influenza virus particles, and of these 36 host proteins 
identified, enzymes downstream of the glycolytic pathway were found to be 
incorporated into the virus particles (Shaw et al., 2008). Some of these host proteins 
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include glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate-6-
kinase (P6K), enolase (ENO) and pyruvate kinase (PKM2). It is tempting to 
hypothesize that influenza virus makes use of a mechanism to assemble downstream 
glycolytic enzymes into the virus particles, shifting the direction of host cell 
metabolism from the glycolytic pathway to ether lipid biosynthesis. 
 
Incidentally, the aPC levels were also decreased in influenza virus-infected cells 
(Figure 3.2). This observation also provides additional evidence that influenza virus 
could possibly redirect metabolic flux in their favour.  
 
It is widely known that  DHAP can be converted to sn-glycerol-3-phosphate (GP) by 
glycerophosphate dehydrogenase (GPD), which in turn leads to the synthesis of 
triglyceride and other glycerolipids (Grimaldi et al., 1978). Since DHAP is a substrate 
required for the first step of ether lipid biosynthesis through formation of acyl-DHAP 
by DHAPAT enzyme, a direct link between the metabolism of ether lipids and non-
ether glycerolipids can be established (Figure 4.2). Furthermore, in differentiating 
preadipocytes, an acyl-DHAP:NADPH reductase have been shown to divert the acyl-
DHAP needed for ether lipid biosynthesis to triglyceride and non-ether glycerolipid 
biosynthesis (Hajra et al., 2000). This could explain why a negative correlation 
between ester and ether-linked PC lipids was observed. Influenza virus could 
therefore make use of such complex host metabolism, to redirect metabolic flux.  
 




Figure 4.2 Triglyceride synthesis pathway (Hajra et al., 2000). 
 
It can be hypothesized that the regulation of host metabolism by influenza virus 
particles could occur upstream of the ether lipid biosynthesis, redirecting flux towards 
ether lipid biosynthesis and away from other non-ether glycerolipids. This is further 
evident when rescue experiments conducted with the addition of a naturally occurring 
ether lipid precursor, 1-O-hexadecyl-sn-glycerol (HG) did not rescue the phenotypic 
effect on influenza virus infectivity (Figure 6.5). It has been shown that addition of 
20µM HG could restore ether lipid levels in ether lipid-deficient cell lines, NRel-4 
((Nagan et al., 1998); findings from the lab), but addition of HG did not rescue virus 
infectivity both in NRel-4 cells (Figure 6.5B) and AGPS knockdown cells (Figure 
6.5A). Plaque assays conducted on NRel-4 cells and AGPS knockdown A549 cells, 
after addition of 20µM HG still showed significant reduction (unpaired Student’s t-
test; two-tailed; p<0.05) in plaque formation as compared to the non-treated control 
cells (CHO-K1 and –ve ctrl A549 cells respectively). Therefore, the addition of HG 
could possibly restore ether lipid levels in cells, but since influenza virus infection 
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hypothetically requires a tight regulation of metabolic flux rather than an increased 
flux of ether lipid biosynthesis alone, restoring ether lipid levels may not be sufficient 
to rescue phenotypic effects on influenza virus infection.  
 
4.3 Conclusion 
In conclusion, significant lipid changes were identified in influenza virus-infected 
cells, and these lipids can be associated with functional roles in influenza virus life 
cycle stages. However, the mechanism of action and the regulation of these lipids by 
influenza virus still remains to be elucidated. From this study, it can be suggested that 
influenza virus may require specific class of lipids for life cycle progression, but this 
may be regulated on a more complex flux system. The balance of the metabolic flux 
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Table 1 List of standards and concentrations used in MS profiling. 




Table 2 m/z value of lipid species analyzed in this study. 





Table 3 Knockdown effect of AGPS siRNA and the off-target effects. 
The percentage knockdown effect after treatment with AGPS s16248 and s16249 siRNA were calculated relative to the –ve ctrl siRNA. The off-target effect of the siRNA 









Figure 6.1 PE and PC lipid species were significantly changed in AGPS knockdown cells.   
PE and PC lipid species were included in the plot above, based on significant difference (p<0.05; unpaired t-test; two-tailed) observed in at least one AGPS siRNA construct, 
with same trends observed in the other construct. The average log (AGPS KD/-ve ctrl) in each independent experiment is represented in (A) and (B). The ester-linked lipid 
species were generally up-regulated and the ether-linked lipid species were down-regulated.  




Table 4 Knockdown effect of Rab11a siRNA and the off-target effects. 
The percentage knockdown effect after treatment with Rab11a s16703 and s16704 siRNA were calculated relative to the –ve ctrl siRNA. The off-target effect of the siRNA 












Figure 6.2 Rab11a protein expression decreased after Rab11a siRNA knockdown 
Rab11a protein expression was greatly reduced after A549 cells were transfected with 12nM s16703 






Figure 6.3 A549 cells were viable after Rab11a siRNA knockdown.  
MTT cell viability assay was conducted after A549 cells were transfected with Rab11a siRNA for 
48hrs. Rab11a siRNA constructs, s16703 and s16704 at 12nM, 6nM and 3nM concentrations had 80 to 
100% of the cells still viable, relative to the –ve ctrl siRNA treated cells. 




Figure 6.4 Western blot of influenza virus-infected cells after AGPS and Rab11a knockdown 
Influenza virus protein, M2, had no change in protein expression levels after AGPS and Rab11a siRNA 
knockdown.  
 




Figure 6.5 Effects of reduced ether lipid levels on influenza virus infection were not rescued by 
addition of ether lipid precursor, 1-O-hexadecyl-sn-glycerol (HG). 
AGPS siRNA knockdown A549 cells (A) and ether lipid-deficient CHO cells, NRel-4 (B) had 
decreased virus titer after treatment with ether lipid precursor, 1-O-hexadecyl-sn-glycerol (HG). 
Similar trends showing decreased virus titer were also observed in non-treated (NT) cells.  
